 |
PDBsum entry 1ha9
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Protease inhibitor
|
PDB id
|
|
|
|
1ha9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Protease inhibitor
|
 |
|
Title:
|
 |
Solution structure of the squash trypsin inhibitor mcoti-ii, nmr, 30 structures.
|
|
Structure:
|
 |
Trypsin inhibitor ii. Chain: a. Synonym: mcoti-ii. Other_details: squash trypsin inhibitor
|
|
Source:
|
 |
Momordica cochinchinensis. Organism_taxid: 3674. Other_details: seeds
|
|
NMR struc:
|
 |
30 models
|
 |
|
Authors:
|
 |
A.Heitz,J.-F.Hernandez,J.Gagnon,T.T.Hong,T.T.C.Pham,T.M.Nguyen,D.Le- Nguyen,L.Chiche
|
Key ref:
|
 |
A.Heitz
et al.
(2001).
Solution structure of the squash trypsin inhibitor MCoTI-II. A new family for cyclic knottins.
Biochemistry,
40,
7973-7983.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
02-Apr-01
|
Release date:
|
12-Apr-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P82409
(ITR2_MOMCO) -
Trypsin inhibitor 2 from Momordica cochinchinensis
|
|
|
|
Seq: Struc:
|
 |
 |
 |
34 a.a.
34 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
40:7973-7983
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of the squash trypsin inhibitor MCoTI-II. A new family for cyclic knottins.
|
|
A.Heitz,
J.F.Hernandez,
J.Gagnon,
T.T.Hong,
T.T.Pham,
T.M.Nguyen,
D.Le-Nguyen,
L.Chiche.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The "knottin" fold is a stable cysteine-rich scaffold, in which one disulfide
crosses the macrocycle made by two other disulfides and the connecting backbone
segments. This scaffold is found in several protein families with no
evolutionary relationships. In the past few years, several homologous peptides
from the Rubiaceae and Violaceae families were shown to define a new structural
family based on macrocyclic knottin fold. We recently isolated from Momordica
cochinchinensis seeds the first known macrocyclic squash trypsin inhibitors.
These compounds are the first members of a new family of cyclic knottins. In
this paper, we present NMR structural studies of one of them, MCoTI-II, and of a
beta-Asp rearranged form, MCoTI-IIb. Both compounds display similar and
well-defined conformations. These cyclic squash inhibitors share a similar
conformation with noncyclic squash inhibitors such as CPTI-II, and it is
postulated that the main effect of the cyclization is a reduced sensitivity to
exo-proteases. On the contrary, clear differences were detected with the
three-dimensional structures of other known cyclic knottins, i.e., kalata B1 or
circulin A. The two-disulfide cystine-stabilized beta-sheet motif [Heitz et al.
(1999) Biochemistry 38, 10615-10625] is conserved in the two families, whereas
in the C-to-N linker, one disulfide bridge and one loop are differently located.
The molecular surface of MCoTI-II is almost entirely charged in contrast to
circulin A that displays a well-marked amphiphilic character. These differences
might explain why the isolated macrocyclic squash inhibitors from M.
cochinchinensis display no significant antibacterial activity, whereas circulins
and kalata B1 do.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.L.Arolas,
and
S.Ventura
(2011).
Protease inhibitors as models for the study of oxidative folding.
|
| |
Antioxid Redox Signal,
14,
97.
|
 |
|
|
|
|
 |
N.L.Daly,
K.J.Rosengren,
S.T.Henriques,
and
D.J.Craik
(2011).
NMR and protein structure in drug design: application to cyclotides and conotoxins.
|
| |
Eur Biophys J,
40,
359-370.
|
 |
|
|
|
|
 |
K.Jagadish,
and
J.A.Camarero
(2010).
Cyclotides, a promising molecular scaffold for peptide-based therapeutics.
|
| |
Biopolymers,
94,
611-616.
|
 |
|
|
|
|
 |
L.Cascales,
and
D.J.Craik
(2010).
Naturally occurring circular proteins: distribution, biosynthesis and evolution.
|
| |
Org Biomol Chem,
8,
5035-5047.
|
 |
|
|
|
|
 |
R.J.Clark,
and
D.J.Craik
(2010).
Invited reviewnative chemical ligation applied to the synthesis and bioengineering of circular peptides and proteins.
|
| |
Biopolymers,
94,
414-422.
|
 |
|
|
|
|
 |
S.S.Puttamadappa,
K.Jagadish,
A.Shekhtman,
and
J.A.Camarero
(2010).
Backbone dynamics of cyclotide MCoTI-I free and complexed with trypsin.
|
| |
Angew Chem Int Ed Engl,
49,
7030-7034.
|
 |
|
|
|
|
 |
D.J.Craik
(2009).
Circling the enemy: cyclic proteins in plant defence.
|
| |
Trends Plant Sci,
14,
328-335.
|
 |
|
|
|
|
 |
J.Austin,
W.Wang,
S.Puttamadappa,
A.Shekhtman,
and
J.A.Camarero
(2009).
Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I.
|
| |
Chembiochem,
10,
2663-2670.
|
 |
|
|
|
|
 |
A.Heitz,
O.Avrutina,
D.Le-Nguyen,
U.Diederichsen,
J.F.Hernandez,
J.Gracy,
H.Kolmar,
and
L.Chiche
(2008).
Knottin cyclization: Impact on Structure and Dynamics.
|
| |
BMC Struct Biol,
8,
54.
|
 |
|
|
|
|
 |
C.Combelles,
J.Gracy,
A.Heitz,
D.J.Craik,
and
L.Chiche
(2008).
Structure and folding of disulfide-rich miniproteins: insights from molecular dynamics simulations and MM-PBSA free energy calculations.
|
| |
Proteins,
73,
87.
|
 |
|
|
|
|
 |
D.C.Ireland,
C.K.Wang,
J.A.Wilson,
K.R.Gustafson,
and
D.J.Craik
(2008).
Cyclotides as natural anti-HIV agents.
|
| |
Biopolymers,
90,
51-60.
|
 |
|
|
|
|
 |
M.Cemazar,
A.Joshi,
N.L.Daly,
A.E.Mark,
and
D.J.Craik
(2008).
The structure of a two-disulfide intermediate assists in elucidating the oxidative folding pathway of a cyclic cystine knot protein.
|
| |
Structure,
16,
842-851.
|
 |
|
|
|
|
 |
M.Cemazar,
C.W.Gruber,
and
D.J.Craik
(2008).
Oxidative folding of cyclic cystine knot proteins.
|
| |
Antioxid Redox Signal,
10,
103-112.
|
 |
|
|
|
|
 |
O.Avrutina,
H.U.Schmoldt,
D.Gabrijelcic-Geiger,
A.Wentzel,
H.Frauendorf,
C.P.Sommerhoff,
U.Diederichsen,
and
H.Kolmar
(2008).
Head-to-tail cyclized cystine-knot peptides by a combined recombinant and chemical route of synthesis.
|
| |
Chembiochem,
9,
33-37.
|
 |
|
|
|
|
 |
P.Thongyoo,
N.Roqué-Rosell,
R.J.Leatherbarrow,
and
E.W.Tate
(2008).
Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides.
|
| |
Org Biomol Chem,
6,
1462-1470.
|
 |
|
|
|
|
 |
D.J.Craik,
and
N.L.Daly
(2007).
NMR as a tool for elucidating the structures of circular and knotted proteins.
|
| |
Mol Biosyst,
3,
257-265.
|
 |
|
|
|
|
 |
D.J.Craik,
R.J.Clark,
and
N.L.Daly
(2007).
Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins.
|
| |
Expert Opin Investig Drugs,
16,
595-604.
|
 |
|
|
|
|
 |
J.A.Camarero,
R.H.Kimura,
Y.H.Woo,
A.Shekhtman,
and
J.Cantor
(2007).
Biosynthesis of a fully functional cyclotide inside living bacterial cells.
|
| |
Chembiochem,
8,
1363-1366.
|
 |
|
|
|
|
 |
M.R.Plan,
U.Göransson,
R.J.Clark,
N.L.Daly,
M.L.Colgrave,
and
D.J.Craik
(2007).
The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.
|
| |
Chembiochem,
8,
1001-1011.
|
 |
|
|
|
|
 |
P.Thongyoo,
A.M.Jaulent,
E.W.Tate,
and
R.J.Leatherbarrow
(2007).
Immobilized protease-assisted synthesis of engineered cysteine-knot microproteins.
|
| |
Chembiochem,
8,
1107-1109.
|
 |
|
|
|
|
 |
D.J.Craik,
M.Cemazar,
C.K.Wang,
and
N.L.Daly
(2006).
The cyclotide family of circular miniproteins: nature's combinatorial peptide template.
|
| |
Biopolymers,
84,
250-266.
|
 |
|
|
|
|
 |
M.Cemazar,
N.L.Daly,
S.Häggblad,
K.P.Lo,
E.Yulyaningsih,
and
D.J.Craik
(2006).
Knots in rings. The circular knotted protein Momordica cochinchinensis trypsin inhibitor-II folds via a stable two-disulfide intermediate.
|
| |
J Biol Chem,
281,
8224-8232.
|
 |
|
|
|
|
 |
P.Thongyoo,
E.W.Tate,
and
R.J.Leatherbarrow
(2006).
Total synthesis of the macrocyclic cysteine knot microprotein MCoTI-II.
|
| |
Chem Commun (Camb),
(),
2848-2850.
|
 |
|
|
|
|
 |
Z.Liu,
J.Dai,
L.Dai,
M.Deng,
Z.Hu,
W.Hu,
and
S.Liang
(2006).
Function and solution structure of Huwentoxin-X, a specific blocker of N-type calcium channels, from the Chinese bird spider Ornithoctonus huwena.
|
| |
J Biol Chem,
281,
8628-8635.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Z.O.Shenkarev,
K.D.Nadezhdin,
V.A.Sobol,
A.G.Sobol,
L.Skjeldal,
and
A.S.Arseniev
(2006).
Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle.
|
| |
FEBS J,
273,
2658-2672.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
O.Avrutina,
H.U.Schmoldt,
D.Gabrijelcic-Geiger,
D.Le Nguyen,
C.P.Sommerhoff,
U.Diederichsen,
and
H.Kolmar
(2005).
Trypsin inhibition by macrocyclic and open-chain variants of the squash inhibitor MCoTI-II.
|
| |
Biol Chem,
386,
1301-1306.
|
 |
|
|
|
|
 |
A.M.Cole
(2003).
Minidefensins and other antimicrobial peptides: candidate anti-HIV microbicides.
|
| |
Expert Opin Ther Targets,
7,
329-341.
|
 |
|
|
|
|
 |
D.J.Craik,
N.L.Daly,
I.Saska,
M.Trabi,
and
K.J.Rosengren
(2003).
Structures of naturally occurring circular proteins from bacteria.
|
| |
J Bacteriol,
185,
4011-4021.
|
 |
|
|
|
|
 |
N.L.Daly,
R.J.Clark,
and
D.J.Craik
(2003).
Disulfide folding pathways of cystine knot proteins. Tying the knot within the circular backbone of the cyclotides.
|
| |
J Biol Chem,
278,
6314-6322.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.D.McBride,
E.M.Watson,
A.B.Brauer,
A.M.Jaulent,
and
R.J.Leatherbarrow
(2002).
Peptide mimics of the Bowman-Birk inhibitor reactive site loop.
|
| |
Biopolymers,
66,
79-92.
|
 |
|
|
|
|
 |
M.Trabi,
and
D.J.Craik
(2002).
Circular proteins--no end in sight.
|
| |
Trends Biochem Sci,
27,
132-138.
|
 |
|
|
|
|
 |
Q.Kaas,
A.Aumelas,
S.Kubo,
N.Chino,
Y.Kobayashi,
and
L.Chiche
(2002).
The [Lys(-2)-Arg(-1)-des(17-21)]-endothelin-1 peptide retains the specific Arg(-1)-Asp8 salt bridge but reveals discrepancies between NMR data and molecular dynamics simulations.
|
| |
Biochemistry,
41,
11099-11108.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |